26 May 2013
Keywords: fda, oks, sepracor, xophenex, metered-dose, inhaler, food
Article | 21 March 2005
The US Food and Drug Administration has approved Sepracor's New Drug Application for Xophenex HFA (levalbuterol tartrate) Inhalation Aerosol,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com